{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:43:56Z","timestamp":1790484236347,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180055"],"award-info":[{"award-number":["RP180055"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health, National Cancer Institute","award":["CA224672"],"award-info":[{"award-number":["CA224672"]}]},{"name":"Mays Cancer Center, UT Health San Antonio"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA054174"],"award-info":[{"award-number":["P30 CA054174"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00213-019-05274-4","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:00:28Z","timestamp":1559044828000},"page":"3183-3195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vortioxetine reverses medial prefrontal cortex-mediated cognitive deficits in male rats induced by castration as a model of androgen deprivation therapy for prostate cancer"],"prefix":"10.1007","volume":"236","author":[{"given":"Alexandra M.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suphada","family":"Lertphinyowong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha S.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gelfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Johnson-Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April L.","family":"Risinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-6258","authenticated-orcid":false,"given":"David A.","family":"Morilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"5274_CR1","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1021\/jm101459g","volume":"54","author":"B Bang-Anderson","year":"2011","unstructured":"Bang-Anderson B et al (2011) Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem 54:3206\u20133221","journal-title":"J Med Chem"},{"key":"5274_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep12726","volume":"5","author":"D Becker","year":"2015","unstructured":"Becker D, Deller T, Vlachos A (2015) Tumor necrosis factor (TNF)-receptor 1 and 2 mediate homeostatic synaptic plasticity of denervated mouse dentate granule cells. Sci Rep 5:12726. \n                    https:\/\/doi.org\/10.1038\/srep12726","journal-title":"Sci Rep"},{"key":"5274_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.npp.1301410","volume":"33","author":"CO Bondi","year":"2008","unstructured":"Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA (2008) Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 33:320\u2013331. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1301410","journal-title":"Neuropsychopharmacology"},{"key":"5274_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.pnpbp.2010.04.016","volume":"34","author":"CO Bondi","year":"2010","unstructured":"Bondi CO, Jett JD, Morilak DA (2010) Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex. Prog Neuro-Psychopharmacol Biol Psychiatry 34:913\u2013923. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2010.04.016","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5274_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/1471-2407-12-371","volume":"12","author":"HH Chao","year":"2012","unstructured":"Chao HH, Uchio E, Zhang S, Hu S, Bednarski SR, Luo X, Rose M, Concato J, Li CSR (2012) Effects of androgen deprivation on brain function in prostate cancer patients\u2014a prospective observational cohort analysis. BMC Cancer 12:371","journal-title":"BMC Cancer"},{"key":"5274_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072032","volume":"8","author":"HH Chao","year":"2013","unstructured":"Chao HH, Hu S, Ide JS, Uchio E, Zhang S, Rose M, Concato J, Li CSR (2013) Effects of androgen deprivation on cerebral morphometry in prostate cancer patients\u2014an exploratory study. PLoS One 8:e72032","journal-title":"PLoS One"},{"key":"5274_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.euroneuro.2015.12.018","volume":"26","author":"F Chen","year":"2016","unstructured":"Chen F, du Jardin KG, Waller JA, Sanchez C, Nyengaard JR, Wegener G (2016) Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus. Eur Neuropsychopharmacol 26:234\u2013245. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.12.018","journal-title":"Eur Neuropsychopharmacol"},{"key":"5274_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/pon.1401","volume":"18","author":"MM Cherrier","year":"2009","unstructured":"Cherrier MM, Aubin S, Higano CS (2009) Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psychooncology 18:237\u2013247. \n                    https:\/\/doi.org\/10.1002\/pon.1401","journal-title":"Psychooncology"},{"key":"5274_CR9","doi-asserted-by":"publisher","first-page":"649079","DOI":"10.1155\/2012\/649079","volume":"2012","author":"SA Correa","year":"2012","unstructured":"Correa SA, Eales KL (2012) The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduction 2012:649079. \n                    https:\/\/doi.org\/10.1155\/2012\/649079","journal-title":"J Signal Transduction"},{"key":"5274_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<52::AID-SSU8>3.0.CO;2-6","volume":"18","author":"LJ Denis","year":"2000","unstructured":"Denis LJ, Griffiths K (2000) Endocrine treatment in prostate cancer. Semin Surg Oncol 18:52\u201374","journal-title":"Semin Surg Oncol"},{"key":"5274_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2016.05.029","volume":"786","author":"KG du Jardin","year":"2016","unstructured":"du Jardin KG, M\u00fcller HK, Sanchez C, Wegener G, Elfving B (2016) A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex. Eur J Pharmacol 786:29\u201335","journal-title":"Eur J Pharmacol"},{"key":"5274_CR12","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/npp.2016.127","volume":"41","author":"EA Fucich","year":"2016","unstructured":"Fucich EA, Paredes D, Morilak DA (2016) Therapeutic effects of extinction learning as a model of exposure therapy in rats. Neuropsychopharmacology 41:3092\u20133102. \n                    https:\/\/doi.org\/10.1038\/npp.2016.127","journal-title":"Neuropsychopharmacology"},{"key":"5274_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.urolonc.2009.09.004","volume":"29","author":"SM Gilbert","year":"2011","unstructured":"Gilbert SM, Kuo YF, Shahinian VB (2011) Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol Oncol 29:647\u2013653. \n                    https:\/\/doi.org\/10.1016\/j.urolonc.2009.09.004","journal-title":"Urol Oncol"},{"key":"5274_CR14","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1200\/JCO.2014.60.1963","volume":"33","author":"BD Gonzalez","year":"2015","unstructured":"Gonzalez BD, Jim HSL, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, Jacobsen PB (2015) Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison. J Clin Oncol 33:2021\u20132027","journal-title":"J Clin Oncol"},{"key":"5274_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1464-410X.2002.02917.x","volume":"90","author":"HJ Green","year":"2002","unstructured":"Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, Mactaggart PN, Swanson C, Watson RB, Gardiner RA (2002) Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 90:427\u2013432","journal-title":"BJU Int"},{"key":"5274_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-017-0563-1","volume":"19","author":"D Gupta","year":"2017","unstructured":"Gupta D, Salmane C, Slovin S, Steingart RM (2017) Cardiovascular complications of androgen deprivation therapy for prostate cancer. Curr Treat Options Cardiovasc Med 19:61. \n                    https:\/\/doi.org\/10.1007\/s11936-017-0563-1","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"5274_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1210\/en.2006-1626","volume":"148","author":"T Hajszan","year":"2007","unstructured":"Hajszan T, MacLusky NJ, Johansen JA, Jordan CL, Leranth C (2007) Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats. Endocrinology 148:1963\u20131967. \n                    https:\/\/doi.org\/10.1210\/en.2006-1626","journal-title":"Endocrinology"},{"key":"5274_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.yhbeh.2007.12.007","volume":"53","author":"T Hajszan","year":"2008","unstructured":"Hajszan T, MacLusky NJ, Leranth C (2008) Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm Behav 53:638\u2013646","journal-title":"Horm Behav"},{"key":"5274_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.yhbeh.2013.02.007","volume":"63","author":"WR Hawley","year":"2013","unstructured":"Hawley WR, Grissom EM, Martin RC, Halmos MB, Bart CL, Dohanich GP (2013) Testosterone modulates spatial recognition memory in male rats. Horm Behav 63:559\u2013565. \n                    https:\/\/doi.org\/10.1016\/j.yhbeh.2013.02.007","journal-title":"Horm Behav"},{"key":"5274_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/aja.2011.107","volume":"14","author":"RJ Jamadar","year":"2012","unstructured":"Jamadar RJ, Winters MJ, Maki PM (2012) Cognitive changes associated with ADT: a review of the literature. Asian J Androl 14:232\u2013238. \n                    https:\/\/doi.org\/10.1038\/aja.2011.107","journal-title":"Asian J Androl"},{"key":"5274_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1464-410X.2005.05565.x","volume":"96","author":"VA Jenkins","year":"2005","unstructured":"Jenkins VA, Bloomfield DJ, Shilling VM, Edginton TL (2005) Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study. BJU Int 96:48\u201353. \n                    https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05565.x","journal-title":"BJU Int"},{"key":"5274_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/npp.2012.216","volume":"38","author":"JD Jett","year":"2013","unstructured":"Jett JD, Morilak DA (2013) Too much of a good thing: blocking noradrenergic facilitation in medial prefrontal cortex prevents the detrimental effects of chronic stress on cognition. Neuropsychopharmacology 38:585\u2013595. \n                    https:\/\/doi.org\/10.1038\/npp.2012.216","journal-title":"Neuropsychopharmacology"},{"key":"5274_CR23","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1007\/s00213-015-3957-3","volume":"232","author":"JD Jett","year":"2015","unstructured":"Jett JD, Boley AM, Girotti M, Shah A, Lodge DJ, Morilak DA (2015) Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway. Psychopharmacology 232:3123\u20133133. \n                    https:\/\/doi.org\/10.1007\/s00213-015-3957-3","journal-title":"Psychopharmacology"},{"key":"5274_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.neuroscience.2017.01.017","volume":"346","author":"JD Jett","year":"2017","unstructured":"Jett JD, Bulin SE, Hatherall LC, McCartney CM, Morilak DA (2017) Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex. Neuroscience 346:284\u2013297. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2017.01.017","journal-title":"Neuroscience"},{"key":"5274_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","volume":"27","author":"C Katona","year":"2012","unstructured":"Katona C, Hansen T, Olsen CK (2012) A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27:215\u2013223","journal-title":"Int Clin Psychopharmacol"},{"key":"5274_CR26","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/endo.136.8.7628354","volume":"136","author":"JE Kerr","year":"1995","unstructured":"Kerr JE, Allore RJ, Beck SG, Handa RJ (1995) Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology 136:3213\u20133221. \n                    https:\/\/doi.org\/10.1210\/endo.136.8.7628354","journal-title":"Endocrinology"},{"issue":"3","key":"5274_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0269881116667710","volume":"31","author":"Pirathiv Kugathasan","year":"2016","unstructured":"Kugathasan P et al. (2017) In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity J Psychopharmacol 31:365-376","journal-title":"Journal of Psychopharmacology"},{"key":"5274_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.neuroscience.2005.09.031","volume":"137","author":"MDS Lapiz","year":"2006","unstructured":"Lapiz MDS, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039\u20131049. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2005.09.031","journal-title":"Neuroscience"},{"key":"5274_CR29","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1523\/JNEUROSCI.23-05-01588.2003","volume":"23","author":"C Leranth","year":"2003","unstructured":"Leranth C, Petnehazy O, MacLusky NJ (2003) Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci 23:1588\u20131592","journal-title":"J Neurosci"},{"key":"5274_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2015.05.013","volume":"135","author":"Y Li","year":"2015","unstructured":"Li Y, Abdourahman A, Tamm JA, Pehrson AL, Sanchez C, Gulinello M (2015) Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice. Pharmacol Biochem Behav 135:70\u201382","journal-title":"Pharmacol Biochem Behav"},{"key":"5274_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159734","volume":"11","author":"Y Libert","year":"2016","unstructured":"Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D (2016) Vulnerabilities in older patients when cancer treatment is initiated: does a cognitive impairment impact the two-year survival? PLoS One 11:e0159734. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0159734","journal-title":"PLoS One"},{"key":"5274_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuroscience.2005.12.054","volume":"138","author":"NJ MacLusky","year":"2006","unstructured":"MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C (2006) Androgen modulation of hippocampal synaptic plasticity. Neuroscience 138:957\u2013965","journal-title":"Neuroscience"},{"key":"5274_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/npp.2015.52","volume":"40","author":"AR Mahableshwarkar","year":"2015","unstructured":"Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RSE (2015) A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40:2025\u20132037","journal-title":"Neuropsychopharmacology"},{"key":"5274_CR34","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1017\/S1461145714000546","volume":"17","author":"RS McIntyre","year":"2014","unstructured":"McIntyre RS, Lophaven S, Olsen CK (2014) A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol 17:1557\u20131567","journal-title":"Int J Neuropsychopharmacol"},{"key":"5274_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyw055","volume":"19","author":"RS McIntyre","year":"2016","unstructured":"McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK (2016) The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol 19:1\u20139","journal-title":"Int J Neuropsychopharmacol"},{"key":"5274_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1200\/jco.2015.63.6266","volume":"34","author":"KT Nead","year":"2016","unstructured":"Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley JT, Leeper NJ, Shah NH (2016) Androgen deprivation therapy and future Alzheimer\u2019s disease risk. J Clin Oncol 34:566\u2013571. \n                    https:\/\/doi.org\/10.1200\/jco.2015.63.6266","journal-title":"J Clin Oncol"},{"key":"5274_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaoncol.2016.3662","volume":"3","author":"KT Nead","year":"2017","unstructured":"Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH (2017) Association between androgen deprivation therapy and risk of dementia. JAMA oncology 3:49\u201355. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2016.3662","journal-title":"JAMA oncology"},{"key":"5274_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/cncr.23658","volume":"113","author":"CJ Nelson","year":"2008","unstructured":"Nelson CJ, Lee JS, Gamboa MC, Roth AJ (2008) Cognitive effects of hormone therapy in men with prostate cancer. Cancer 113:1097\u20131106","journal-title":"Cancer"},{"key":"5274_CR39","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pon.592","volume":"11","author":"WF Pirl","year":"2002","unstructured":"Pirl WF, Siegel GI, Goode MJ, Smith MR (2002) Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psycho-oncology 11:518\u2013523","journal-title":"Psycho-oncology"},{"key":"5274_CR40","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47","journal-title":"Nucleic Acids Res"},{"key":"5274_CR41","doi-asserted-by":"publisher","unstructured":"Russell N, Grossmann M (2018) Management of bone and metabolic effects of androgen deprivation therapy urologic oncology doi:\n                    https:\/\/doi.org\/10.1016\/j.urolonc.2018.10.007","DOI":"10.1016\/j.urolonc.2018.10.007"},{"key":"5274_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","volume":"145","author":"C Sanchez","year":"2015","unstructured":"Sanchez C, Asin KE, Artigas F (2015) Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacol Ther 145:43\u201357. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2014.07.001","journal-title":"Pharmacol Ther"},{"key":"5274_CR43","unstructured":"Sharp AM et al. (2017) Vortioxetine reverses cognitive impairment induced by castration as a model of androgen deprivation therapy for prostate cancer in male rats Neuroscience Meeting Planner Washington, D C: Society for Neuroscience Program No. 520.03"},{"key":"5274_CR44","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.juro.2006.06.087","volume":"176","author":"EJ Siddiqui","year":"2006","unstructured":"Siddiqui EJ, Shabbir M, Mikhailidis DP, Thompson CS, Mumtaz FH (2006) The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation. J Urol 176:1648\u20131653. \n                    https:\/\/doi.org\/10.1016\/j.juro.2006.06.087","journal-title":"J Urol"},{"issue":"1","key":"5274_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"Rebecca L. Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018 CA Cancer J Clin 68:7\u201330 doi:\n                    https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"5274_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cne.902940107","volume":"294","author":"RB Simerly","year":"1990","unstructured":"Simerly RB, Chang C, Muramatsu M, Swanson LW (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294:76\u201395. \n                    https:\/\/doi.org\/10.1002\/cne.902940107","journal-title":"J Comp Neurol"},{"key":"5274_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107\u20131112","journal-title":"J Natl Cancer Inst"},{"key":"5274_CR48","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1017\/S1461145714000571","volume":"17","author":"A Wallace","year":"2014","unstructured":"Wallace A, Pehrson AL, S\u00e1nchez C, Morilak DA (2014) Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats. Int J Neuropsychopharmacol 17:1695\u20131706. \n                    https:\/\/doi.org\/10.1017\/S1461145714000571","journal-title":"Int J Neuropsychopharmacol"},{"key":"5274_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.euroneuro.2016.11.014","volume":"27","author":"JA Waller","year":"2017","unstructured":"Waller JA, Tamm JA, Abdourahman A, Pehrson AL, Li Y, Cajina M, Sanchez C (2017) Chronic vortioxetine treatment in rodents modulates gene expression of neurodevelopmental and plasticity markers. Eur Neuropsychopharmacol 27:192\u2013203","journal-title":"Eur Neuropsychopharmacol"},{"key":"5274_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003901","volume":"4","author":"S Watts","year":"2014","unstructured":"Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4:e003901","journal-title":"BMJ Open"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05274-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05274-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:16:53Z","timestamp":1590535013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05274-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5274"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05274-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"21 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Texas Health, San Antonio, and are compliant with the ethical standards of the National Institutes of Health as specified in the Guide for the Care and Use of Laboratory Animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Vortioxetine was provided by H. Lundbeck A\/S, which had no input into the conduct of the study, analysis or interpretation of the data, and no role in the decision to publish or in the writing of the manuscript. Dr. Morilak receives research funding from Alkermes that has no relation to the present work. All other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}